MIM
SRZN icon

MetLife Investment Management’s Surrozen SRZN Stock Holding History

MetLife Investment Management’s Portfolio SRZN Stock Details SRZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122K Buy
+4,699
New +$129K ﹤0.01% 2696

Other funds holding SRZN

CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MetLife Investment Management's SRZN Position: Q2 2026 in Review

MetLife Investment Management opened a new position in Surrozen (SRZN) in Q2 2026: 4,699 shares worth $122K. The stake represents ﹤0.01% of the portfolio and ranks #2696 among its holdings.

70 funds tracked by Wall St. Rank hold SRZN as of Q2 2026.

  • MetLife Investment Management held 4,699 shares of Surrozen worth $122K as of Q2 2026.
  • Surrozen was a new MetLife Investment Management position in Q2 2026.
  • Surrozen made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2696 holding.
  • 70 funds tracked by Wall St. Rank held Surrozen as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.